U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 13:43:14 GMT 2025
Edited
by admin
on Wed Apr 02 13:43:14 GMT 2025
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1|KAPPA
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
WPL7XBK5KU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BNT-323
Preferred Name English
Trastuzumab Pamirtecan
INN  
Official Name English
trastuzumab pamirtecan [INN]
Common Name English
immunoglobulin G1-kappa, anti-[Homo sapiens ERBB2 (receptor tyrosine-protein kinase erbB-2, epidermal growth factor receptor 2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)], humanized monoclonal antibody,conjugated on an average of eight cysteinyl resid
Common Name English
TRASTUZUMAB PAMIRTECAN [USAN]
Common Name English
Immunoglobulin G1 [de-450-lysine], anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal DB-1303 ?1-chain), disulfide with human-Mus musculus monoclonal DB-1303 ?-chain, dimer, thioether with N-[6-(3-mercapto-2,5-dioxo-1-pyrro
Common Name English
H-gamma1 heavy chain humanized (1-449) [VH (Homo sapiens IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (217) (121-218), hinge 1-
Common Name English
DB-1303
Code English
Code System Code Type Description
NCI_THESAURUS
C188319
Created by admin on Wed Apr 02 13:43:14 GMT 2025 , Edited by admin on Wed Apr 02 13:43:14 GMT 2025
PRIMARY
USAN
MN-147
Created by admin on Wed Apr 02 13:43:14 GMT 2025 , Edited by admin on Wed Apr 02 13:43:14 GMT 2025
PRIMARY
INN
13179
Created by admin on Wed Apr 02 13:43:14 GMT 2025 , Edited by admin on Wed Apr 02 13:43:14 GMT 2025
PRIMARY
CAS
2792722-57-5
Created by admin on Wed Apr 02 13:43:14 GMT 2025 , Edited by admin on Wed Apr 02 13:43:14 GMT 2025
PRIMARY
FDA UNII
WPL7XBK5KU
Created by admin on Wed Apr 02 13:43:14 GMT 2025 , Edited by admin on Wed Apr 02 13:43:14 GMT 2025
PRIMARY
From To
1_22 1_96
2_22 2_96
2_147 2_203
2_223 4_214
2_264 2_324
1_147 1_203
2_370 2_428
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_223 3_214
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION RESIDUE_SPECIFIC C Amount: UNSPECIFIED SUBSTANCE
de6f3fcb
(not in database)
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL